Perinatal hypophosphatasia (HPP) is a rare, potentially life-threatening, inherited, systemic metabolic bone disease that can be difficult to recognize in utero and postnatally. Diagnosis is challenging because of the large number of skeletal dysplasias with overlapping clinical features. This review focuses on the role of fetal and neonatal imaging modalities in the differential diagnosis of perinatal HPP from other skeletal dysplasias (e.g., osteogenesis imperfecta, campomelic dysplasia, achondrogenesis subtypes, hypochondrogenesis, cleidocranial dysplasia). Perinatal HPP is associated with a broad spectrum of imaging findings that are characteristic of but do not occur in all cases of HPP and are not unique to HPP, such as shortening, bo...
Hypophosphatasia (HPP) is a rare inherited metabolic disease in which mutations in the ALPL gene (en...
Congenital hypophosphatasia is a rare fatal skeletal dysplasia. Antenatal determinants of Epub ahead...
Background Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by loss-of-functi...
Lethal skeletal disorders represent a heterogeneous and clinically variable group of genetic conditi...
Hypophosphatasia (HPP), from deactivating mutation(s) within the “tissue nonspecific” alkaline phosp...
Hypophosphatasia is a rare and lethal metabolic bone disease characterised by low or absent serum an...
Hypophosphatasia is a rare hereditary disorder of bone metabolism.In this article, we presented the ...
Hypophosphatasia (HPP) is a group of inherited disorders characterised by the impaired mineralisatio...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135621/1/jum2005245707.pd
Bone disease in the neonatal period has often been regarded as an issue affecting premature infants,...
Abstract. Hypophosphatasia is a rare inherited disorder caused by deficient tissue-nonspecific alkal...
Hypophosphatasia (HPP) is caused by loss-of-function mutation(s) within the gene TNSALP that encodes...
A premature male infant was delivered at 32 weeks' gestation due to category-2 fetal tracing after p...
International audienceHypophosphatasia (HPP) is a rare inherited skeletal dysplasia due to loss of f...
Hypophosphatasia (HPP) is the heritable metabolic disease characterized by impaired skeletal mineral...
Hypophosphatasia (HPP) is a rare inherited metabolic disease in which mutations in the ALPL gene (en...
Congenital hypophosphatasia is a rare fatal skeletal dysplasia. Antenatal determinants of Epub ahead...
Background Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by loss-of-functi...
Lethal skeletal disorders represent a heterogeneous and clinically variable group of genetic conditi...
Hypophosphatasia (HPP), from deactivating mutation(s) within the “tissue nonspecific” alkaline phosp...
Hypophosphatasia is a rare and lethal metabolic bone disease characterised by low or absent serum an...
Hypophosphatasia is a rare hereditary disorder of bone metabolism.In this article, we presented the ...
Hypophosphatasia (HPP) is a group of inherited disorders characterised by the impaired mineralisatio...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/135621/1/jum2005245707.pd
Bone disease in the neonatal period has often been regarded as an issue affecting premature infants,...
Abstract. Hypophosphatasia is a rare inherited disorder caused by deficient tissue-nonspecific alkal...
Hypophosphatasia (HPP) is caused by loss-of-function mutation(s) within the gene TNSALP that encodes...
A premature male infant was delivered at 32 weeks' gestation due to category-2 fetal tracing after p...
International audienceHypophosphatasia (HPP) is a rare inherited skeletal dysplasia due to loss of f...
Hypophosphatasia (HPP) is the heritable metabolic disease characterized by impaired skeletal mineral...
Hypophosphatasia (HPP) is a rare inherited metabolic disease in which mutations in the ALPL gene (en...
Congenital hypophosphatasia is a rare fatal skeletal dysplasia. Antenatal determinants of Epub ahead...
Background Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by loss-of-functi...